FDA Issues Emergency Use Authorization For Roche's New COVID
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
Get authentic, real-time news that helps you fight COVID-19 better.
Install PlexusMD App for doctors. It's free.
Roche's Elecsys® Anti-SARS-CoV-2 S antibody test has received Emergency Use Authorization from the U.S. Food and Drug Administration (FDA). It measures the level of antibodies in people who have been exposed to the SARS-CoV-2 virus.

The test targets antibodies that are directed against the region of the novel coronavirus known as the spike protein which is required for the virus to enter the host cell. The test provides a numerical result describing the concentration of antibodies from 0.40-250 U/mL as well as a qualitative result.

Antibody tests like these will play a critical role in measuring a person’s vaccine-induced immune response and may also help to guide the allocation of plasma donations from recovered Covid-19 patients to current patients by identifying donors that have antibodies to SARS-CoV-2 virus.

Source:
https://health.economictimes.indiatimes.com/news/diagnostics/roche-receives-fda-emergency-use-authorization-for-new-test-to-measure-the-level-of-sars-cov-2-antibodies/79528697
Dr. J●●●●●h A●●●●i and 2 other likes this
Like
Comment
Share